Efficacy and safety of the fixed-dose combination regimen of MK3 [MK-3682/grazoprevir/ruzasvir] with or without ribavirin in non-cirrhotic or cirrhotic patients with chronic HCV GT1, 2, 3, 4 or 6 infection (Parts A & B of C-CREST-1 & 2)

2017 ◽  
Vol 66 (1) ◽  
pp. S315-S316 ◽  
Author(s):  
E. Lawitz ◽  
E.M. Yoshida ◽  
M. Buti ◽  
J.M. Vierling ◽  
P.L. Almasio ◽  
...  
Author(s):  
Leila Boussoffara ◽  
Marwa Ammar ◽  
Nadia Boudawara ◽  
Soumaya Bouchareb ◽  
Imen Touil ◽  
...  

Pneumologie ◽  
2016 ◽  
Vol 70 (S 01) ◽  
Author(s):  
ED Bateman ◽  
K Chapman ◽  
S Rennard ◽  
L Rekeda ◽  
M Moya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document